TRDA Entrada Therapeutics
- 12.450
- +0.090+0.73%
- 12.450
- 0.0000.00%
Entrada Therapeutics News
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 152.48K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 25, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 12,483 shares of its common stock on Apr 25, with a total market value of approximately $152.48
Edgewise Gets EU Orphan Drug Status for Muscular Dystrophy Drug
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 116.17K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 19, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 9,632 shares of its common stock on Apr 19, with a total market value of approximately $116.17K
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 112.7K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 18, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 9,311 shares of its common stock on Apr 18, with a total market value of approximately $112.7K.
GLYC, APLD and AUTL Are Among After Hour Movers
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersOntrak (NASDAQ:OTRK) shares increased by 18.7% to $0.45 during Thursday's after-market session. The company's market cap stands at $18.9 million. Ocuphire Pharma (NASDAQ:OCUP) stock rose 7.82%
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 110.1K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 11, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 8,510 shares of its common stock on Apr 11, with a total market value of approximately $110.1K.
Insiders Buying America's Car-Mart And 2 Other Stocks
Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
Entrada Therapeutics(TRDA.US) Director Buys US$35,289.8 in Common Stock
$Entrada Therapeutics(TRDA.US)$ Director KIM PETER S purchased 2,600 shares of common stock on Apr 8, 2024 at an average price of $13.573 for a total value of $35,289.8.Source: Announcement What is st
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 176.03K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 10, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 14,096 shares of its common stock on Apr 10, with a total market value of approximately $176.03
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 108.04K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 9, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 8,163 shares of its common stock on Apr 9, with a total market value of approximately $108.04K.
Form 144 | Entrada Therapeutics(TRDA.US) Officer Proposes to Sell 102.59K in Common Stocks
SEC FILLINGS DISCLOSED/ Apr 5, $Entrada Therapeutics(TRDA.US)$ Officer NERISSA C KREHER intends to sell 7,500 shares of its common stock on Apr 5, with a total market value of approximately $102.59K.
Entrada Therapeutics(TRDA.US) Director Buys US$20,793.93 in Common Stock
$Entrada Therapeutics(TRDA.US)$ Director KIM PETER S purchased 1,512 shares of Common Stock on Mar 28, 2024 at an average price of $13.7526 for a total value of $20,793.93.Source: Announcement What is
Director of Entrada Therapeutics Peter Kim Buys 18% More Shares
Potential Entrada Therapeutics, Inc. (NASDAQ:TRDA) shareholders may wish to note that the Director, Peter Kim, recently bought US$123k worth of stock, paying US$13.58 for each share. That's a very
Director Peter Kim Acquires 9,048 Shares of Entrada Therapeutics Inc (TRDA)
Entrada Therapeutics(TRDA.US) Director Buys US$122.88K in Common Stocks
$Entrada Therapeutics(TRDA.US)$ Director KIM PETER S purchased 9,048 shares of Common Stocks on Mar 22, 25, 26, 2024 at an average price of $13.5811 for a total value of $122.88K.Source: Announcement
Around $5M Bet On This Communication Services Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the s
Entrada Therapeutics(TRDA.US) Director Buys US$34,995.55 in Common Stocks
$Entrada Therapeutics(TRDA.US)$ Director KIM PETER S purchased 2,732 shares of Common Stocks on Mar 19, 20, 21, 2024 at an average price of $12.8095 for a total value of $34,995.55.Source: Announcemen
Express News | HC Wainwright & Co. Reiterates Buy on Entrada Therapeutics, Maintains $20 Price Target
Entrada Therapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/18/2024 56.49% HC Wainwright & Co. → $20 Reiterates Buy → Buy 01/05/2024 72.14% Oppenheimer → $22 Initi
Analysis
Price Target
No Data
